anti-MUC1 CAR-pNK cells
PG-121-001
Phase 2 mab active
Quick answer
anti-MUC1 CAR-pNK cells for Hepatocellular Carcinoma is a Phase 2 program (mab) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Hepatocellular Carcinoma
- Phase
- Phase 2
- Modality
- mab
- Status
- active